Filter
1180
Filtered Results: 1180
Text search:
rifampicin
Featured
Recommendations
131
New Publications
309
Language
Document type
No document type
777
Guidelines
169
Studies & Reports
97
Manuals
58
Strategic & Response Plan
27
Training Material
20
Fact sheets
20
Situation Updates
7
Infographics
3
App
1
Resource Platforms
1
Countries / Regions
India
62
Western and Central Europe
60
Eastern Europe
36
Nepal
27
South Africa
27
Kenya
22
Latin America and the Carribbean
22
Argentina
19
Tanzania
18
Colombia
16
Nigeria
15
Peru
15
Global
14
Germany
14
Paraguay
14
Bangladesh
14
Uganda
14
Namibia
14
Ethiopia
14
Zambia
13
Indonesia
13
Rwanda
12
Malawi
12
Brazil
12
El Salvador
11
Senegal
11
Myanmar / Burma
11
Ukraine
10
Philippines
10
Bolivia
10
Cambodia
9
South–East Asia Region
9
Cameroon
8
Mozambique
8
Asia
8
Congo, Democratic Republic of
8
Africa
7
Russia
7
Tajikistan
5
Ghana
5
Benin
5
Zimbabwe
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Chile
4
Burkina Faso
4
Venezuela
4
Botswana
4
Liberia
4
Madagascar
4
Lesotho
3
Sierra Leone
3
Haiti
3
Georgia
3
Bhutan
3
Pakistan
3
Timor Leste/ East Timor
2
Syria
2
Armenia
2
Jordan
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Central African Republic
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Guinea
1
USA
1
Dominican Republic
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Tunisia
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
270
TB
88
Guidelines
74
Studies & Reports
57
Drugs & Medical Equipment
49
Capacity Building
33
Policies
26
Women & Child Health
23
Pediatrics
22
HIV & STI
22
Statistics
18
Disease Prevention & Control
13
Community Health
12
Paediatrics
11
Bacteriology
9
Reproductive Health
9
Buruli Ulcer
8
COVID-19
8
Leprosy
8
Dermatology
7
Leprosy
7
Family Planning
6
Maternal & Child Health
5
Countries
5
Clinical Guidelines
5
Demograhic Health Surveys DHS
5
Communicable Diseases
5
NTDs & Others
5
Community Health
4
Vaccine-preventable Diseases
4
Communicable Diseases
3
Infection Control & Prevention (IPC)
3
Public Health
3
Health Systems
3
Clinical Training
2
Hepatitis
2
Under-5 nutrition
2
Diabetes
2
Trachoma
2
Lymphaticfilariasis
2
Humanitarian Aid
2
Monitoring & Evaluation
2
Virology
2
Medical Devices & Equipment
2
Information, Education and Communication (IEC)
2
Humanitarian Crisis
2
Other
2
General Guidelines
2
Leishmaniasis
2
Dental & Eye Care
1
Public Health
1
Pharmacy & Technology
1
Child Health
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
Palliative Care
1
IEC Material
1
Health System Strengthening
1
NCD
1
Disabilities
1
Palliative Care
1
Respiratory Infections
1
Needs Assessment
1
Primary Health Care
1
Malaria
1
Pharmacy & Technologies
1
Toolboxes
Prevention & Control
57
Drug resistant TB
55
Detection & Diagnosis
52
Adults
49
Children
31
Training
26
TB/HIV Coinfection
25
Essential Medicines & Devices Lists
23
TB & Prisoners
20
Reports
19
Childhood TB
18
Antiretroviral Treatment ART
18
Policies & Strategies
15
General
15
Research & Access
15
Clinical Aspects, Treatment & Prevention
14
Children & Adolescents
14
Disease Prevention & Control
14
TB
14
Treatment & Prevention
13
Laboratory
13
Clinical Aspects & Diagnostics
13
Clinical Aspects
12
Colombia
12
Peru
12
Argentina
12
AmR (Region of Americas)
12
Eastern Europe & Central Asia
12
Brazil
11
Other Countries
11
Romania
11
Germany
11
Country specific
10
Reports & Studies
10
SEAR (South-east Asia Region)
10
Moldova
9
Policies & Strategies
9
Treatment Guidelines HIV
9
Prevention & Control
9
El Salvador
9
Essential Medicines
9
Studies & Reports
9
TB & Drug Abuse
8
TB & Other Vulnerable Populations
8
International
8
TB/HIV
8
General
8
HIV and coinfection
8
Biosafety
7
South Africa
7
Country Guidelines
7
Advocacy & Communication
7
HIV &TB
7
Policies and guidelines
7
Tuberculosis
7
Clinical Guidelines
7
Kenya
7
Treatment & Clinical Management
7
Opportunistic Infections
6
Namibia
6
Drug resistance
6
Communication & Training
6
Studies
6
Community Health Workers CHW
6
Overview
6
TB/HIV Global
6
Uganda
6
South-east Asia Region
6
Epidemiology
6
ART Drug Resistance
5
Ukraine
5
IEC Materials
5
Rwanda
5
TB/COVID-19
5
Rational use of Medicine
5
Diagnosis
5
Malawi
5
Nutrition
5
Latin America & the Carribean
5
Assessment
5
General Reports
4
Azerbaijan
4
Vaccines & Immunization
4
Training Manuals
4
TB
4
SOPs
4
Ethiopia
4
Clinical Guidelines
4
Clinical Guidelines
4
Country Specific
4
Chile
4
Ecuador
4
Falsified & Substandard
4
Co-Morbidities (except TB)
4
Prophylactic Treatment
4
Nigeria
4
Tajikistan
4
Kazakhstan
4
Western & Central Europe
4
Eastern Europe and central Asia
4
Agriculture & Veterinary
3
Epidemiology & Sitreps
3
Eastern Mediterranean Region
3
National Policies
3
Mozambique
3
Georgia
3
Clinical aspects
3
Workplace
3
Essential List
3
Country specific documents
3
Global Impact: Socio-economic, health services, TB & HIV
3
Hospital Readiness/Essential Health Services
3
Latin America
3
Others
3
Pharmacy Practice
3
Information & Education Material (IEC)
3
Capacity Building & Resource platforms
3
Access to treatment and laboratory
3
Drugs
2
Behaviour Change/Life Skill Education
2
Meningitis Prevention & Control
2
Clinical Guidelines
2
Pediatrics
2
WPRO (Western Pacific Region)
2
Prevention Guidelines
2
Policies
2
HIV
2
Prophylaxis
2
Health & Refugee
2
Laboratory
2
Epilepsy
2
Sustainable Development Goals
2
Russia
2
General
2
Latin America
2
Prices and Patents
2
Model Formulary
2
Guidelines & Manuals
2
Prevention & Measures
2
Disability Prevention & Rehabilitation
2
NTDs General
2
Health Worker
2
Neurological Disorders
2
Ghana
2
HIV service delivery
2
Lobby and Advocacy
2
Meningitis & Encephalitis
2
Clinical Guidelines
1
Assessment & Studies
1
Surveillance
1
HIV testing & services
1
Clinical Guidelines
1
Zambia
1
Social Mobilisation
1
Social Worker
1
Public Health
1
Eastern Europe
1
Global
1
People who injecting Drugs
1
Vaccination
1
African Region
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
DR Congo
1
Laboratory
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Research & Development
1
Handbooks & Manuals
1
Primary Care
1
Nurses
1
Estonia
1
Pharmacy Management
1
Pharmaceutical Assessments
1
Supply Chain & Store Management
1
General documents One Health
1
General
1
Health Care In Conflict Settings
1
Leishmaniasis
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Clinical Aspects & Diagnostics
1
Vector control
1
Armenia
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Botswana
1
General
1
Substance Use Disorders & Addiction
1
Community Worker
1
General Aspects
1
Regional Reports & Guidelines, others
1
AR (African Region)
1
Education of students & professionals
1
Lesotho
1
Stewardship
1
HIV / AIDS
1
Testing Guidelines
1
Others
1
Stigma
1
Overview & Statistics
1
MHPSS Guidelines
1
Guidelines CBR
1
Reports & Studies Children HIV
1
HIV in Key Populations
1
Preparedness & Prevention
1
Global Health Financing
1
Unaccompanied Refugee Minors
1
Case Definitions
1
Prisoners
1
Key Resources
1
AMR
1
Volunteers
1
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Глобальными приоритетами для лечения туберкулеза (ТБ) и борьбы с ним являются улучшенное и ранее выявление случаев туберкулеза, в том числе случаев заболевания с о...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Автоматизированная технология амплификации нуклеиновых кислот в режиме реального времени для быстрого и одновременного выявления туберкулеза и устойчивости к р...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
La publicación describe el funcionamiento del método rápido, confiable, sencillo y económico al laboratorio que permita examinar un gran número de muestras a fin de seleccionar a aquellos pacientes que pudieran estar potencialmente infectados con Mycobacterium tuberculosis multirresistente a lo...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed TB resistant isoniazid (INH). Drug resistance must be detected rapidly and accurately to initiate appr...
